痛风药物非布司他售价多少？

(Alias: Febuxostat) is a uric acid-lowering drug with a significant uric acid-lowering effect. It can be used to treat gout. By avoiding gout-inducing factors, uric acid levels can be stabilized. How much does the gout drug Febuxostat cost?

Price of Febuxostat: It is understood that the price of Febuxostat on the domestic market is relatively expensive and is not suitable for patients to take it for a long time. What I need to tell you here is that the efficacy of Febuxostat produced by Zydus Pharmaceutical Factory in India is the same as that of the original drug. The price is indeed much lower. The specification is 80mg*30 tablets/box. Its price is about 200$. Due to the floating exchange rate, the price is different. Please consult the medical companion for the specific price!

We need to remind everyone that febuxostat can control gout but cannot cure gout. Uric acid-lowering treatment for gout patients is a long-term process. Once the blood uric acid reaches the target, the drug cannot be stopped at will. The drug must be reduced or stopped according to the doctor's advice based on the uric acid level.

Unauthorized discontinuation of uric acid-lowering drugs can easily cause blood uric acid to return to the pre-treatment level, which can not only cause another gout attack, but long-term failure of blood uric acid to reach the standard will also bring the risk of kidney, cardiovascular and cerebrovascular damage.

Medication is an important part of treating gout, but lifestyle changes are also essential.

Who should not use Febuxostat?

Patients with a history of allergies to the ingredients of Febuxostat tablets.

In patients taking mercaptopurine or azathioprine, febuxostat may cause increased plasma concentrations of azathioprine, mercaptopurine and theophylline and increased toxicity.

Febuxostat (alias: febuxostat) has not been studied in patients with secondary hyperuricemia, and therefore its use is not recommended in patients with secondary hyperuricemia.

Not recommended for use in patients with asymptomatic hyperuricemia.

Recommended related hot articles: /newsDetail/74630.html